AI Engines For more Details: Perplexity Kagi Labs You
Pain Relief: Fenoprofen is primarily used to relieve mild to moderate pain, including musculoskeletal pain (such as that caused by arthritis, sprains, strains, or back pain) and pain from conditions like menstrual cramps and headaches.
Anti-Inflammatory Effects: Fenoprofen has anti-inflammatory properties, meaning it helps reduce inflammation in the body. This can be beneficial for conditions characterized by inflammation, such as rheumatoid arthritis and osteoarthritis.
Fever Reduction: Like other NSAIDs, fenoprofen can help reduce fever by acting on the hypothalamus, the part of the brain that regulates body temperature. It is sometimes used to alleviate fever associated with infections or inflammatory conditions.
Dysmenorrhea Relief: Fenoprofen may be used to alleviate the pain and discomfort associated with dysmenorrhea (menstrual cramps) by reducing uterine contractions and inflammation in the pelvic region.
Management of Rheumatic Conditions: Fenoprofen is commonly prescribed for the management of rheumatic conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and juvenile rheumatoid arthritis. It helps alleviate pain, stiffness, and inflammation associated with these conditions.
Postoperative Pain Relief: Fenoprofen may be used for the management of postoperative pain, particularly after procedures such as dental extractions, minor surgeries, or orthopedic procedures. It can help reduce pain and swelling at the surgical site.
Side Effects: Common side effects of fenoprofen include gastrointestinal upset (such as nausea, indigestion, and stomach pain), headache, dizziness, drowsiness, and skin rash. Long-term use of NSAIDs like fenoprofen can increase the risk of gastrointestinal ulcers, bleeding, and kidney damage. It may also elevate blood pressure and increase the risk of cardiovascular events, particularly in individuals with pre-existing heart disease or hypertension.
Contraindications: Fenoprofen is contraindicated in individuals with a history of hypersensitivity to NSAIDs, aspirin, or other related medications. It should be used with caution in individuals with a history of gastrointestinal ulcers or bleeding, kidney impairment, heart failure, or hypertension.
Drug Interactions: Fenoprofen may interact with other medications, including blood thinners (anticoagulants), corticosteroids, certain antidepressants, lithium, methotrexate, and other NSAIDs. Concurrent use of multiple NSAIDs can increase the risk of adverse effects.
Dosage and Administration: Fenoprofen is typically taken orally in the form of tablets or capsules. The dosage and frequency of administration depend on the individual's age, medical condition, and response to treatment. It is important to follow the healthcare provider's instructions and not exceed the recommended dosage.
Rank | Probiotic | Impact |
---|---|---|
species | Akkermansia muciniphila | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.4 | -0.4 | |
ADHD | 3.6 | 0.4 | 8 |
Age-Related Macular Degeneration and Glaucoma | 0.6 | 0 | 0 |
Allergic Rhinitis (Hay Fever) | 0.6 | 2 | -2.33 |
Allergies | 4.4 | 2.4 | 0.83 |
Allergy to milk products | 0.7 | 0.5 | 0.4 |
Alopecia (Hair Loss) | 1.2 | 1.2 | |
Alzheimer's disease | 2.1 | 3.5 | -0.67 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 3.1 | 1.1 | 1.82 |
Ankylosing spondylitis | 3 | 0.9 | 2.33 |
Anorexia Nervosa | 0 | 1.6 | 0 |
Antiphospholipid syndrome (APS) | 0.8 | 0.8 | |
Asthma | 1.2 | 1.5 | -0.25 |
Atherosclerosis | 1 | 1.4 | -0.4 |
Atrial fibrillation | 2.7 | 1.2 | 1.25 |
Autism | 6.2 | 7.1 | -0.15 |
Barrett esophagus cancer | 0.4 | 0.1 | 3 |
benign prostatic hyperplasia | 0.1 | 0.1 | |
Bipolar Disorder | 0.5 | 1.3 | -1.6 |
Brain Trauma | 0.8 | 0.4 | 1 |
Carcinoma | 2.9 | 2.3 | 0.26 |
Celiac Disease | 1.3 | 3.9 | -2 |
Cerebral Palsy | 1.4 | 1.1 | 0.27 |
Chronic Fatigue Syndrome | 3.5 | 4.1 | -0.17 |
Chronic Kidney Disease | 0.9 | 1.2 | -0.33 |
Chronic Lyme | 0.4 | -0.4 | |
Chronic Obstructive Pulmonary Disease (COPD) | 0.8 | 0.7 | 0.14 |
Chronic Urticaria (Hives) | 1 | 1.2 | -0.2 |
Coagulation / Micro clot triggering bacteria | 0.5 | 1 | -1 |
Colorectal Cancer | 2 | 0.9 | 1.22 |
Constipation | 0.7 | 0.7 | 0 |
Coronary artery disease | 0.8 | 1 | -0.25 |
COVID-19 | 9.6 | 10.6 | -0.1 |
Crohn's Disease | 4.3 | 4.3 | 0 |
cystic fibrosis | 0.3 | 0.8 | -1.67 |
deep vein thrombosis | 0.3 | 0.5 | -0.67 |
Depression | 5.9 | 5.9 | 0 |
Dermatomyositis | 0.1 | 0.4 | -3 |
Eczema | 0.7 | 0.9 | -0.29 |
Endometriosis | 2 | 1.3 | 0.54 |
Eosinophilic Esophagitis | 0.4 | -0.4 | |
Epilepsy | 2.1 | 2.2 | -0.05 |
Fibromyalgia | 1.3 | 1.4 | -0.08 |
Functional constipation / chronic idiopathic constipation | 3.3 | 1.8 | 0.83 |
gallstone disease (gsd) | 1.6 | 0.6 | 1.67 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.4 | 1 | -1.5 |
Generalized anxiety disorder | 0.9 | 1.6 | -0.78 |
giant cell arteritis | 0.1 | -0.1 | |
Glioblastoma | 0.1 | -0.1 | |
Gout | 0.1 | -0.1 | |
Graves' disease | 1 | 1.4 | -0.4 |
Halitosis | 0.6 | 0.1 | 5 |
Hashimoto's thyroiditis | 2.1 | 0.6 | 2.5 |
Hidradenitis Suppurativa | 0.1 | 0.4 | -3 |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 2.7 | 0.6 | 3.5 |
hypercholesterolemia (High Cholesterol) | 0.4 | 0.7 | -0.75 |
hyperglycemia | 0.1 | 2.2 | -21 |
Hyperlipidemia (High Blood Fats) | 1.2 | 0.4 | 2 |
hypersomnia | 0.4 | -0.4 | |
hypertension (High Blood Pressure | 1.8 | 4.2 | -1.33 |
Hypothyroidism | 1.3 | -1.3 | |
Hypoxia | 0.6 | 0.6 | |
IgA nephropathy (IgAN) | 2.9 | -2.9 | |
Inflammatory Bowel Disease | 2.4 | 5.9 | -1.46 |
Insomnia | 0.8 | 0.8 | 0 |
Intelligence | 0.2 | 0.4 | -1 |
Intracranial aneurysms | 0.8 | 0.4 | 1 |
Irritable Bowel Syndrome | 3.1 | 3.1 | 0 |
Liver Cirrhosis | 3.4 | 2.5 | 0.36 |
Long COVID | 4.6 | 7.8 | -0.7 |
Low bone mineral density | 0.7 | -0.7 | |
Lung Cancer | 0.3 | 1.7 | -4.67 |
ME/CFS with IBS | 0.2 | 2.5 | -11.5 |
ME/CFS without IBS | 1.5 | 1.8 | -0.2 |
Menopause | 2.4 | 2.4 | |
Metabolic Syndrome | 5.1 | 6.3 | -0.24 |
Mood Disorders | 8.3 | 6.2 | 0.34 |
multiple chemical sensitivity [MCS] | 1.2 | 0.4 | 2 |
Multiple Sclerosis | 4.8 | 2.4 | 1 |
Multiple system atrophy (MSA) | 1.9 | 1 | 0.9 |
Neuropathy (all types) | 1 | 0.1 | 9 |
neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2 | 5.4 | -1.7 |
NonCeliac Gluten Sensitivity | 0.4 | -0.4 | |
Obesity | 6.4 | 3.8 | 0.68 |
obsessive-compulsive disorder | 4.1 | 3.3 | 0.24 |
Osteoarthritis | 0.8 | 0.2 | 3 |
Osteoporosis | 1.3 | 1.4 | -0.08 |
pancreatic cancer | 0.4 | 0.4 | |
Parkinson's Disease | 2.7 | 2.2 | 0.23 |
Polycystic ovary syndrome | 1 | 1.7 | -0.7 |
Postural orthostatic tachycardia syndrome | 0.1 | 0.5 | -4 |
Premenstrual dysphoric disorder | 1.3 | 0 | 0 |
primary biliary cholangitis | 0.4 | 0.4 | 0 |
Psoriasis | 3.8 | 1.8 | 1.11 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 5.1 | 2.5 | 1.04 |
Rosacea | 0.7 | 0.3 | 1.33 |
Schizophrenia | 5.8 | 1.4 | 3.14 |
scoliosis | 0.1 | 0.9 | -8 |
Sjögren syndrome | 2.7 | 2.3 | 0.17 |
Sleep Apnea | 1.1 | 1.3 | -0.18 |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.4 | 0.8 | -1 |
Stress / posttraumatic stress disorder | 1.9 | 2.8 | -0.47 |
Systemic Lupus Erythematosus | 2.2 | 1.9 | 0.16 |
Tic Disorder | 0.5 | 1.6 | -2.2 |
Tourette syndrome | 0.4 | 0.2 | 1 |
Type 1 Diabetes | 2.2 | 1.6 | 0.38 |
Type 2 Diabetes | 5 | 4.1 | 0.22 |
Ulcerative colitis | 2 | 3.6 | -0.8 |
Unhealthy Ageing | 2 | 1.6 | 0.25 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.